How Obesity Affects Melanoma Testing
February 7th, 2012 | 
Author: Analysts in Descendants and Community Medication at Thomas Jefferson University or college recently learned that obesity was related to higher rates of prostate cancer screening across all races/ethnic differences and lower rates of cervical cancer screening, most notably in white women. Their study to the role of obesity in cancer screening rates for prostate, cervical and breast and colorectal cancers across race/ethnicity and gender is examined with the current economic issue of the Journal of Obesity.
“Numerous numerous studies have shown suggested that obesity constitutes an obstacle to cancer screening, but a deeper examination also for the role of race/ethnicity and gender within the equation will not be done before,” said Heather Bittner Fagan, MD, FAAFP MPH, lead author and associate professor, Thomas Jefferson University and director of Health Services Research, department of Family and Community Medicine, Christiana Care Health System. “A greater understanding of the relationship between cancer screening and obesity, race/ethnicity and gender will also help explain the association between obesity and increased cancer mortality.”
Obesity is second to tobacco use for a risk factor for cancer and it is regarding prostate pains combined and also for cancer of specific sites, including cancer with the colon/rectum, prostate, breast, and cervix.
Study
In cervical cancer screening, increasing weight was consistently regarding lower rates of Pap smear use. Studies showed this for being perhaps most obviously in white women, with black women, particularly black women of high socioeconomic status showing an absent or weakened association.
Compared, prostate cancer screening levels were consistently proven to increase with weight. In three of 4 studies obese men were quite likely going to obtain a PSA test for prostate cancer screening than their normal weight peers. This unique finding usually remain across race/ethnicity differences.
“This may be explained by variations in access and make use of medical care; as weight increases so do other comorbid conditions, making heavier men higher users of medical care as well as perhaps more inspired to be approved by their care provider,” said Richard Wender, MD, professor at Jefferson Medical College of Thomas Jefferson University and chair of Family and Community Medicine at Thomas Jefferson University Hospital, a writer to the study.
An assessment breast cancers screening research showed no correlation between weight and mammography use within women. Inside the three studies examined that stratified the obesity-screening relationship according to race, one study showed obesity corresponded with a decreased utilization of mammography in white along with increased use within their black counterparts and stages of prostate cancer. 2 of a few studies found a confident association between obesity and mammography use within black women, while one study showed no effect.
Similarly, higher weight women, according to the team’s analysis, were more unlikely for being screened for colorectal cancer (CRC), the data made no mention of disparities in screening levels between races; research showed inconsistencies within the association between obesity and CRC screening in men. The studies available on CRC screening looked at various testing options, making direct comparison difficult. On the whole, research established that endoscopy, not fecal occult blood test (FOBT), was more likely based weight status, specially in women. Researchers surmise that it may be connected with the fact endoscopy is more invasive and for that reason more complicated on obese patients relative to other screening tests.
A conclusion
Cultural differences among men, women, blacks and whites and socioeconomic factors just like insurance status and use of medical care, which is often confounded with race/ethnicity and gender, may limit or grant use of certain cancer screenings.
“We want to have built a much more detailed picture with the relationship between obesity and cancer screening to express to efforts to identify minimizing disparities in cancer screening,” said Fagan and Wender.
“Screening behaviors can vary by ethnicity/race and gender, but more scientific studies are had to create a comprehensive understanding of obesity and cancer screening in race-gender subgroups just like white men, white women, black men and black women, making up the negative impacts with the doctor-patient relationship, use of care and kind of screening test.”
Posted in 
Tags: